BioNTech SE (BNTX) Payables (2018 - 2025)

BioNTech SE has disclosed Payables across 8 years of filings, most recently posting $622.6 million for Q4 2025.

• Payables for Q4 2025 came in at $622.6 million, up 36.55% year-over-year; the trailing twelve-month figure through Dec 2025 was $622.6 million (up 36.55% YoY), and the FY2025 annual result was $604.3 million, up 32.54% from the prior year.
• Payables came in at $622.6 million for Q4 2025 at BioNTech SE, up from $512.4 million in the prior quarter.
• In the past five years, Payables ranged from a high of $949.3 million in Q2 2024 to a low of $34.3 million in Q1 2023.
• The 5-year median for Payables is $434.7 million (2021), against an average of $451.7 million.
• Across the five-year window, Payables sank 89.04% in 2023 and soared 852.35% in 2024, its largest moves.
• BioNTech SE's Payables stood at $379.3 million in 2021, then tumbled by 44.54% to $210.4 million in 2022, then soared by 82.23% to $383.4 million in 2023, then grew by 18.94% to $456.0 million in 2024, then jumped by 36.55% to $622.6 million in 2025.
• The last three Payables figures came in at $622.6 million (Q4 2025), $512.4 million (Q3 2025), and $615.4 million (Q2 2025), per Business Quant data.